Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BB3008 combination therapy in advanced solid tumors
CTR20263588Phase 2Active
- Sponsor
- Bohui Biotech
- Start
- Oct 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of BB3008 in Nonhematologic neoplasms, sponsored by Bohui Biotech. Started Oct 2026; status: active.
02
Drugs
BB3008
03
Conditions
Nonhematologic neoplasms
Beyond the preview
Go deeper on CTR20263588.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20263588.